Mon, Mar 2, 2015, 6:25 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Roche Holding AG Message Board

  • hopplerisking hopplerisking Jun 4, 2012 8:25 PM Flag

    Forbes' Article on Vivus, Roche impact

    Has an owner of Roche’s stock read the article: “Vivus: Qnexa is Not Guaranteed Approval. Remember Provenge? The article addresses the weight loss/obesity marketplace. Is anyone on this blog concerned about the effect Chromadex could have on the entire weight loss/obesity drug market as a whole? Do you think Roche would be adversely affected by potential positive results to be released in the next few weeks? From what I understand, Roche is a direct competitor.

33.987-0.143(-0.42%)Mar 2 3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.